News

Rhythm Pharmaceuticals shares surged to a record high Wednesday on promising results for a drug that could treat a rare form ...
The new Temple Women and Families Hospital near Juniata Park will handle nearly all health system labor and deliveries, as ...
Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...
The Chicago Human Rhythm Project is celebrating 35 years of rhythm, culture and community with Rhythm World, a weeklong ...
Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.
Lee So-mi (26) has occupied an advantageous position for her first major championship in the U.S. Ladies Professional Golf ...
Dum is a mesmerizing auditory journey crafted by rhythm maestros Bickram Ghosh and Taufiq Qureshi. This avant-garde piece ...
Rory McIlroy stressed after the end of the first round that everything seemed a bit chaotic at the beginning, but as the day ...
Rhythm Pharma (RYTM) stock gains as the company's experimental therapy bivamelagon shows promise in Phase 2 trial for rare acquired hypothalamic obesity. Read more here.
Rhythm said results of the recent trial were also consistent with BMI reductions achieved with setmelanotide therapy in similar patient populations in past trials. Setmelanotide, an existing ...
The next program of the Rhythm on the River Arts Series in Grand Rapids will be presented by Lake Effect Clarinet Quartet on ...